Lipocine
LPCN
LPCN
21 hedge funds and large institutions have $1.48M invested in Lipocine in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
21
Holding in Top 10
–
Calls
$424K
Puts
–
Top Buyers
| 1 | +$170K | |
| 2 | +$42.1K | |
| 3 | +$15.3K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$147 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$125 |
Top Sellers
| 1 | -$123K | |
| 2 | -$55.6K | |
| 3 | -$31.3K | |
| 4 |
BlackRock
New York
|
-$16.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.7K |